Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: J Neuroimmunol. 2008 Apr 11;196(1-2):8–15. doi: 10.1016/j.jneuroim.2008.02.004

Table 4.

UA treatment of MBP-immunized PLSJL mice during the first seven days after immunization decrease incidence of paralytic EAE and suppress mortality.

Incidence of paralytic EAE (%) (score > 2) % mortality
UA treated mice 28.6 0
Saline treated mice 52.6 21.1

PLSJL mice were immunized and treated for 7 days with UA (14 mice) or saline (19 mice) as described in a legend for figure 6B. Disease development was monitored for 30 days. Data are represented as percent of mice showing clinical signs of EAE or as a percent mortality.